EUVIMEDEUVIMED entdecken
Crossref

Ultrasensitive clinical identification of hepatitis B surface antigen (HBsAg) by CRISPR-assisted nanopore sensing

Minghan Li, Chengyan Tao, Zhuoyun Tang, Kaiju Li, Yu Wang, Changjian Zhao, Chuanmin Tao, Jia Geng, Ke Sun

Biosensors and Bioelectronics · 2025

DOI: 10.1016/j.bios.2025.117579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Minghan Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative In…. Hauptthemen laut MEDLINE: Biosensing Techniques, Hepatitis B Surface Antigens, Nanopores, Hepatitis B virus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Special Project for Research and Development in Key areas of Guangdong Province, National Natural Science Foundation of China, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus (HBV) infection is a major global health issue. The underdiagnosis of HBV contributes to the increasing mortality from hepatitis B-related complications. Hepatitis B surface antigen is a biomarker guiding the clinical management of chronic hepatitis B, and its disappearance from the blood is a key sign of functional cure. There is a need for highly sensitive detection methods for early intervention and prevention of disease recurrence. We presented a new CRISPR-assisted nanopore sensing method for ultrasensitive detection of hepatitis B surface antigen. It uses the high specificity and turnover efficiency of the CRISPR-Cas12a system. The system is activated by the competitive binding between hepatitis B surface antigen and its aptamer, followed by restriction enzyme digestion. The products are detected by a nanopore for precise quantification at very low concentrations. The result achieves the limit of quantification (LOQ) of 10 fM, outperforming conventional assays. Clinical validation with patient samples confirms its superiority. This integrated technology is a powerful tool for HBV early diagnosis, treatment monitoring, and disease assessment, and paves the way for nanopore technology in clinical diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesHepatitis B Surface AntigensNanoporesHepatitis B virusCRISPR-Cas SystemsHepatitis BHumansLimit of DetectionAptamers, Nucleotide

Stichwörter der Autor:innen

Cas12aClinical detectionHepatitis B surface antigenNanopore detection

Substanzen

Hepatitis B Surface AntigensAptamers, Nucleotide

Autor:innen und Institutionen

  • Department of Laboratory Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu 610041, China.
  • Laboratory of Medicine, West China Hospital of Sichuan University, China.
  • Department of Laboratory Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu 610041, China. Electronic address: taocm@scu.…
  • Department of Laboratory Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu 610041, China; Tianfu Jincheng Laboratory, Ci…
  • Department of Laboratory Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu 610041, China. Electronic address: ke.sun@scu…

Förderung

  • Special Project for Research and Development in Key areas of Guangdong Province
  • National Natural Science Foundation of China
  • Sichuan University
  • National Key Research and Development Program of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Li, M., Tao, C., Tang, Z., Li, K., Wang, Y., Zhao, C., Tao, C., Geng, J., & Sun, K. (2025). Ultrasensitive clinical identification of hepatitis B surface antigen (HBsAg) by CRISPR-assisted nanopore sensing. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.117579

Vancouver

Li M, Tao C, Tang Z, Li K, Wang Y, Zhao C, et al. Ultrasensitive clinical identification of hepatitis B surface antigen (HBsAg) by CRISPR-assisted nanopore sensing. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2025.117579

BibTeX
@article{Li2025,
  author = {Li, Minghan and Tao, Chengyan and Tang, Zhuoyun and Li, Kaiju and Wang, Yu and Zhao, Changjian and Tao, Chuanmin and Geng, Jia and Sun, Ke},
  title = {Ultrasensitive clinical identification of hepatitis B surface antigen (HBsAg) by CRISPR-assisted nanopore sensing},
  journal = {Biosensors and Bioelectronics},
  year = {2025},
  doi = {10.1016/j.bios.2025.117579}
}
Kostenlos starten →